Caspase-1 is a novel target of p63 in tumor suppression

I. Celardo, F. Grespi, A. Antonov, F. Bernassola, A. V. Garabadgiu, G. Melino, I. Amelio

Research output: Contribution to journalArticle

Abstract

p63 is a p53 family transcription factor, which besides unique roles in epithelial development, shares tumor suppressive activity with its homolog p53. The p63 gene has different transcriptional start sites, which generate two N-terminal isoforms (transactivation domain (TA)p63 and amino terminal truncated protein(ΔN)p63); in addition alternative splicing at the 5'-end give rise to at least five C-terminal isoforms. This complexity of gene structure has probably fostered the debate and controversy on p63 function in cancer, with TP63-harboring two distinctive promoters, codifying for the TAp63 and ΔNp63 isoforms, and having discrete functions. However, ΔNp63 also drives expression of target genes that have a relevant role in cancer and metastasis. In this study, we identified a novel p63 transcriptional target, caspase-1. Caspase-1 is proinflammatory caspase, which functions in tumor suppression. We show that both p63 isoforms promote caspase-1 expression by physical binding to its promoter. Consistent with our in vitro findings, we also identified a direct correlation between p63 and caspase-1 expression in human cancer data sets. In addition, survival estimation analysis demonstrated that functional interaction between p63 and caspase-1 represents a predictor of positive survival outcome in human cancers. Overall, our data report a novel p63 target gene involved in tumor suppression, and the clinical analysis underlines the biological relevance of this finding and suggests a further clinically predictive biomarker.

Original languageEnglish
Article numbere645
JournalCell Death and Disease
Volume4
Issue number5
DOIs
Publication statusPublished - May 2013

Fingerprint

Caspase 1
Protein Isoforms
Neoplasms
Genes
Alternative Splicing
Survival Analysis
Caspases
Transcriptional Activation
Transcription Factors
Biomarkers
Neoplasm Metastasis
Gene Expression
Survival

Keywords

  • Bladder cancer
  • Breast cancer
  • Caspase-1
  • P63
  • Prostate cancer
  • Tumor suppression

ASJC Scopus subject areas

  • Cell Biology
  • Immunology
  • Cancer Research
  • Cellular and Molecular Neuroscience

Cite this

Celardo, I., Grespi, F., Antonov, A., Bernassola, F., Garabadgiu, A. V., Melino, G., & Amelio, I. (2013). Caspase-1 is a novel target of p63 in tumor suppression. Cell Death and Disease, 4(5), [e645]. https://doi.org/10.1038/cddis.2013.175

Caspase-1 is a novel target of p63 in tumor suppression. / Celardo, I.; Grespi, F.; Antonov, A.; Bernassola, F.; Garabadgiu, A. V.; Melino, G.; Amelio, I.

In: Cell Death and Disease, Vol. 4, No. 5, e645, 05.2013.

Research output: Contribution to journalArticle

Celardo, I, Grespi, F, Antonov, A, Bernassola, F, Garabadgiu, AV, Melino, G & Amelio, I 2013, 'Caspase-1 is a novel target of p63 in tumor suppression', Cell Death and Disease, vol. 4, no. 5, e645. https://doi.org/10.1038/cddis.2013.175
Celardo, I. ; Grespi, F. ; Antonov, A. ; Bernassola, F. ; Garabadgiu, A. V. ; Melino, G. ; Amelio, I. / Caspase-1 is a novel target of p63 in tumor suppression. In: Cell Death and Disease. 2013 ; Vol. 4, No. 5.
@article{c051a5b6395342bdb28877688626a14e,
title = "Caspase-1 is a novel target of p63 in tumor suppression",
abstract = "p63 is a p53 family transcription factor, which besides unique roles in epithelial development, shares tumor suppressive activity with its homolog p53. The p63 gene has different transcriptional start sites, which generate two N-terminal isoforms (transactivation domain (TA)p63 and amino terminal truncated protein(ΔN)p63); in addition alternative splicing at the 5'-end give rise to at least five C-terminal isoforms. This complexity of gene structure has probably fostered the debate and controversy on p63 function in cancer, with TP63-harboring two distinctive promoters, codifying for the TAp63 and ΔNp63 isoforms, and having discrete functions. However, ΔNp63 also drives expression of target genes that have a relevant role in cancer and metastasis. In this study, we identified a novel p63 transcriptional target, caspase-1. Caspase-1 is proinflammatory caspase, which functions in tumor suppression. We show that both p63 isoforms promote caspase-1 expression by physical binding to its promoter. Consistent with our in vitro findings, we also identified a direct correlation between p63 and caspase-1 expression in human cancer data sets. In addition, survival estimation analysis demonstrated that functional interaction between p63 and caspase-1 represents a predictor of positive survival outcome in human cancers. Overall, our data report a novel p63 target gene involved in tumor suppression, and the clinical analysis underlines the biological relevance of this finding and suggests a further clinically predictive biomarker.",
keywords = "Bladder cancer, Breast cancer, Caspase-1, P63, Prostate cancer, Tumor suppression",
author = "I. Celardo and F. Grespi and A. Antonov and F. Bernassola and Garabadgiu, {A. V.} and G. Melino and I. Amelio",
year = "2013",
month = "5",
doi = "10.1038/cddis.2013.175",
language = "English",
volume = "4",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Caspase-1 is a novel target of p63 in tumor suppression

AU - Celardo, I.

AU - Grespi, F.

AU - Antonov, A.

AU - Bernassola, F.

AU - Garabadgiu, A. V.

AU - Melino, G.

AU - Amelio, I.

PY - 2013/5

Y1 - 2013/5

N2 - p63 is a p53 family transcription factor, which besides unique roles in epithelial development, shares tumor suppressive activity with its homolog p53. The p63 gene has different transcriptional start sites, which generate two N-terminal isoforms (transactivation domain (TA)p63 and amino terminal truncated protein(ΔN)p63); in addition alternative splicing at the 5'-end give rise to at least five C-terminal isoforms. This complexity of gene structure has probably fostered the debate and controversy on p63 function in cancer, with TP63-harboring two distinctive promoters, codifying for the TAp63 and ΔNp63 isoforms, and having discrete functions. However, ΔNp63 also drives expression of target genes that have a relevant role in cancer and metastasis. In this study, we identified a novel p63 transcriptional target, caspase-1. Caspase-1 is proinflammatory caspase, which functions in tumor suppression. We show that both p63 isoforms promote caspase-1 expression by physical binding to its promoter. Consistent with our in vitro findings, we also identified a direct correlation between p63 and caspase-1 expression in human cancer data sets. In addition, survival estimation analysis demonstrated that functional interaction between p63 and caspase-1 represents a predictor of positive survival outcome in human cancers. Overall, our data report a novel p63 target gene involved in tumor suppression, and the clinical analysis underlines the biological relevance of this finding and suggests a further clinically predictive biomarker.

AB - p63 is a p53 family transcription factor, which besides unique roles in epithelial development, shares tumor suppressive activity with its homolog p53. The p63 gene has different transcriptional start sites, which generate two N-terminal isoforms (transactivation domain (TA)p63 and amino terminal truncated protein(ΔN)p63); in addition alternative splicing at the 5'-end give rise to at least five C-terminal isoforms. This complexity of gene structure has probably fostered the debate and controversy on p63 function in cancer, with TP63-harboring two distinctive promoters, codifying for the TAp63 and ΔNp63 isoforms, and having discrete functions. However, ΔNp63 also drives expression of target genes that have a relevant role in cancer and metastasis. In this study, we identified a novel p63 transcriptional target, caspase-1. Caspase-1 is proinflammatory caspase, which functions in tumor suppression. We show that both p63 isoforms promote caspase-1 expression by physical binding to its promoter. Consistent with our in vitro findings, we also identified a direct correlation between p63 and caspase-1 expression in human cancer data sets. In addition, survival estimation analysis demonstrated that functional interaction between p63 and caspase-1 represents a predictor of positive survival outcome in human cancers. Overall, our data report a novel p63 target gene involved in tumor suppression, and the clinical analysis underlines the biological relevance of this finding and suggests a further clinically predictive biomarker.

KW - Bladder cancer

KW - Breast cancer

KW - Caspase-1

KW - P63

KW - Prostate cancer

KW - Tumor suppression

UR - http://www.scopus.com/inward/record.url?scp=84879380549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879380549&partnerID=8YFLogxK

U2 - 10.1038/cddis.2013.175

DO - 10.1038/cddis.2013.175

M3 - Article

C2 - 23703390

AN - SCOPUS:84879380549

VL - 4

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 5

M1 - e645

ER -